(Q47953864)

7 February 2018

title

Anti-oligomeric single chain variable domain antibody differentially affects huntingtin and alpha-synuclein aggregates. (English)

1 reference

7 February 2018

1 reference

1 reference

1

1 reference

7 February 2018

author name string

Andleeb Zameer

series ordinal

2

1 reference

7 February 2018

Michael R Sierks

series ordinal

3

1 reference

7 February 2018

language of work or name

English

0 references

publication date

28 January 2008

1 reference

7 February 2018

published in

FEBS Letters

1 reference

7 February 2018

volume

582

1 reference

7 February 2018

issue

4

1 reference

7 February 2018

page(s)

517-522

1 reference

7 February 2018

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

Trinucleotide repeat length and progression of illness in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

Common mechanisms of amyloid oligomer pathogenesis in degenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

Single chain Fv antibodies against the 25-35 Abeta fragment inhibit aggregation and toxicity of Abeta42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

Monoclonal antibodies that target pathological assemblies of Abeta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.014

10.1016/J.FEBSLET.2008.01.014

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

18230361

1 reference

7 February 2018